Cardiothoracic & vascular anesthesia

Protracted fibrinolysis resistance following cardiac surgery with cardiopulmonary bypass: A prospective observational study of clinical associations and patient outcomes

Acta Anaesthesiol ScandPublished Prospective observational study

Authors' conclusion

This observational hypothesis-generating study in patients undergoing cardiac surgery with cardiopulmonary bypass demonstrated an association between the severity of fibrinolysis resistance, measured on the first post-operative day, and the need for extended postoperative ICU level support.

Study context

Population
Patients after cardiac surgery with cardiopulmonary bypass (CPB)
Participants
52 patients
Outcome
Kinetics of fibrinolysis recovery post-CPB (ClotPro TPA-induced clot lysis time, TPA LT) and its correlation with surgical risk, disease severity, organ dysfunction and ICU LOS
Methodological detailshypothesis-generating
  • Hypothesis-generating

Main finding

As reported in the abstract

Correlations of TPA LT on post-operative day 1 · first post-operative day (D1)
EuroScore II, Spearman's rho (p < .01)
.39
Time on CPB, rho (p = .04)
.35
APACHE II, rho (p < .001)
.52
SOFA, rho (p < .001)
.51
Duration of invasive ventilation, rho (p < .01)
.46
eGFR, rho (p < .001)
−.65

Observational data: associations, not effects.

Further findings

ICU LOS (generalized linear regression with TPA LT, CPB run time, organ function markers)

OR (95% CI)P value
TPA LTOnly TPA LT independently associated1.03 (1.01–1.05)P = 0.01

Mediation by renal function (latent variables analysis)

Association between TPA LT and ICU LOS not mediated by renal function

Original publication

Protracted fibrinolysis resistance following cardiac surgery with cardiopulmonary bypass: A prospective observational study of clinical associations and patient outcomes. Acta Anaesthesiol Scand. Published 18 March 2024. doi:10.1111/aas.14409

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.